Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder

NCT06086275 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Opioid Use Disorder

Interventions

DRUG: Buprenorphine

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]